Isolation of high-affinity monomeric human Anti-c-erbB-2 single chain Fv using affinity-driven selection

被引:253
作者
Schier, R
Bye, J
Apell, G
McCall, A
Adams, GP
Malmqvist, M
Weiner, LM
Marks, JD
机构
[1] UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, DEPT ANESTHESIA & PHARMACEUT, SAN FRANCISCO, CA 94110 USA
[2] BLOOD TRANSFUS SERV, CAMBRIDGE, ENGLAND
[3] CHIRON CORP, EMERYVILLE, CA 94608 USA
[4] FOX CHASE CANC CTR, DEPT MED ONCOL, PHILADELPHIA, PA 19111 USA
[5] PHARMACIA BISENSOR AB, S-75182 UPPSALA, SWEDEN
关键词
c-erbB-2; single chain Fv; phage antibody libraries; affinity maturation; chain shuffling;
D O I
10.1006/jmbi.1996.0004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The use of antibodies to target tumor antigens has had limited success, partially due to the large size of IgG molecules, difficulties in constructing smaller single chain Fv (scFv) antibody fragments, and immunogenicity of murine antibodies. These limitations can be overcome by selecting human scFv directly from non-immune or semi-synthetic phage antibody libraries; however, the affinities are typically too low for therapeutic application. For hapten antigens, higher-affinity scFv can be isolated from phage antibody libraries where the V-H and V-L genes of a binding scFv are replaced with repertoires of V genes (chain shuffling). The applicability of this approach to protein binding scFv is unknown. For this work, chain shuffling was used to increase the affinity of a non-immune human scFv, which binds the glycoprotein tumor antigen c-erbB-2 with an affinity of 1.6 x 10(-8) M. The affinity of the parental scFv was increased sixfold (K-d = 2.5 x 10(-9) M) by light-chain shuffling and fivefold (K-d = 3.1 x 10(-9)M) by heavy-chain shuffling, values comparable to those for antibodies against the same antigen produced by hybridomas. When selections were performed on antigen immobilized on polystyrene, spontaneously dimerizing scFv were isolated, the best of which had only a slightly lower K-d than wild type (K-d = 1.1 x 10(-8) M). These scFv dimerize on phage and are preferentially selected as a result of increased avidity Compared to scFv which formed only monomer, dimerizing scFv had mutations located at the V-H-V-L interface, suggesting that V-H-V-L complementarity determines the extent of dimerization. Higher-affinity monomeric scFv were only obtained by selecting in solution using limiting concentrations of biotinylated antigen, followed by screening mutant scFv from bacterial periplasm by k(off) in a BIAcore. Using the proper selection and screening conditions, protein binding human scFv with affinities comparable to murine hybridomas can be produced without immunization. (C) 1996 Academic Press Limited
引用
收藏
页码:28 / 43
页数:16
相关论文
共 71 条
  • [1] ADAMS GP, 1993, CANCER RES, V53, P4026
  • [2] IN-VITRO EVOLUTION OF A NEUTRALIZING HUMAN-ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO ENHANCE AFFINITY AND BROADEN STRAIN CROSS-REACTIVITY
    BARBAS, CF
    HU, D
    DUNLOP, N
    SAWYER, L
    CABABA, D
    HENDRY, RM
    NARA, PL
    BURTON, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 3809 - 3813
  • [3] MOLECULAR PROFILE OF AN ANTIBODY-RESPONSE TO HIV-1 AS PROBED BY COMBINATORIAL LIBRARIES
    BARBAS, CF
    COLLET, TA
    AMBERG, W
    ROBEN, P
    BINLEY, JM
    HOEKSTRA, D
    CABABA, D
    JONES, TM
    WILLIAMSON, RA
    PILKINGTON, GR
    HAIGWOOD, NL
    CABEZAS, E
    SATTERTHWAIT, AC
    SANZ, I
    BURTON, DR
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1993, 230 (03) : 812 - 823
  • [4] MUTATION DRIFT AND REPERTOIRE SHIFT IN THE MATURATION OF THE IMMUNE-RESPONSE
    BEREK, C
    MILSTEIN, C
    [J]. IMMUNOLOGICAL REVIEWS, 1987, 96 : 23 - 41
  • [5] SINGLE-CHAIN ANTIGEN-BINDING PROTEINS
    BIRD, RE
    HARDMAN, KD
    JACOBSON, JW
    JOHNSON, S
    KAUFMAN, BM
    LEE, SM
    LEE, T
    POPE, SH
    RIORDAN, GS
    WHITLOW, M
    [J]. SCIENCE, 1988, 242 (4877) : 423 - 426
  • [6] A SURFACE EXPRESSION VECTOR FOR ANTIBODY SCREENING
    BREITLING, F
    DUBEL, S
    SEEHAUS, T
    KLEWINGHAUS, I
    LITTLE, M
    [J]. GENE, 1991, 104 (02) : 147 - 153
  • [7] HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY
    CARTER, P
    PRESTA, L
    GORMAN, CM
    RIDGWAY, JBB
    HENNER, D
    WONG, WLT
    ROWLAND, AM
    KOTTS, C
    CARVER, ME
    SHEPARD, HM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4285 - 4289
  • [8] DOMAIN ASSOCIATION IN IMMUNOGLOBULIN MOLECULES - THE PACKING OF VARIABLE DOMAINS
    CHOTHIA, C
    NOVOTNY, J
    BRUCCOLERI, R
    KARPLUS, M
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1985, 186 (03) : 651 - 663
  • [9] MAKING ANTIBODY FRAGMENTS USING PHAGE DISPLAY LIBRARIES
    CLACKSON, T
    HOOGENBOOM, HR
    GRIFFITHS, AD
    WINTER, G
    [J]. NATURE, 1991, 352 (6336) : 624 - 628
  • [10] CLAUSS MA, 1990, CANCER RES, V50, P3487